We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

162 hedge funds and large institutions have $589M invested in Natus Medical Inc in 2013 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 10

154% more call options, than puts

Call options by funds: $6.84M | Put options by funds: $2.69M

59% more capital invested

Capital invested by funds: $372M → $589M (+$218M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

22% more funds holding

Funds holding: 133162 (+29)

12% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 51

Holders
162
Holders Change
+29
Holders Change %
+21.8%
% of All Funds
4.7%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
40
Increased
57
Reduced
51
Closed
10
Calls
$6.84M
Puts
$2.69M
Net Calls
+$4.15M
Net Calls Change
+$4.65M
Name Holding Trade Value Shares
Change
Change in
Stake
EAM
1
Eagle Asset Management
Florida
$39.2M +$7.33M +379,466 +28%
BFA
2
BlackRock Fund Advisors
California
$38.2M -$2.31M -119,360 -7%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$31.9M -$627K -32,490 -2%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$31.3M +$1.56M +80,894 +6%
Bank of New York Mellon
5
Bank of New York Mellon
New York
$28.5M +$407K +21,057 +2%
CCM
6
Corsair Capital Management
New York
$24.9M -$70.7K -3,661 -0.3%
Vanguard Group
7
Vanguard Group
Pennsylvania
$24.7M +$331K +17,140 +2%
BC
8
Broadfin Capital
New York
$22.8M -$29.1M -1,506,876 -60%
Diamond Hill Capital Management
9
Diamond Hill Capital Management
Ohio
$21.9M -$647K -33,480 -3%
BIT
10
BlackRock Institutional Trust
California
$21.4M -$710K -36,771 -4%
KCM
11
Kennedy Capital Management
Missouri
$15.2M -$120K -6,196 -0.9%
TAM
12
THB Asset Management
Connecticut
$13.9M +$307K +15,920 +3%
State Street
13
State Street
Massachusetts
$13.5M +$71.3K +3,691 +0.6%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$13.5M
Northern Trust
15
Northern Trust
Illinois
$11.4M +$15.3K +792 +0.2%
TC
16
TFS Capital
Pennsylvania
$10.4M +$4.27M +220,928 +92%
MFAM
17
Motley Fool Asset Management
Virginia
$9.82M
BCM
18
Beddow Capital Management
Wyoming
$9.27M -$152K -7,875 -2%
RFC
19
Russell Frank Company
Washington
$8.99M +$560K +28,999 +9%
RCMC
20
RK Capital Management (Colorado)
Colorado
$8.99M -$2.72M -140,985 -26%
CPIM
21
Columbia Partners Investment Management
Virginia
$7.63M -$4.77M -246,977 -42%
Boston Partners
22
Boston Partners
Massachusetts
$7.14M -$2.92M -151,090 -32%
Goldman Sachs
23
Goldman Sachs
New York
$6.35M +$3.92M +202,781 +255%
Norges Bank
24
Norges Bank
Norway
$6.3M
Fuller & Thaler Asset Management
25
Fuller & Thaler Asset Management
California
$6.14M +$5.27M +272,875 New

NTUS Hedge Fund Activity: Q4 2013 in Review

162 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2013, worth a combined $589M — up 59% from $372M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new NTUS positions and 10 closed out — a net gain of 30 holders — while 57 added to existing stakes and 51 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $7.33M. The largest seller was Broadfin Capital, cutting an estimated $29.1M.

  • 162 institutional investors held Natus Medical Inc (NTUS) as of Q4 2013, up from 133 in Q3 2013.
  • Funds reported $589M of Natus Medical Inc stock for Q4 2013, up 59% quarter-over-quarter.
  • 40 funds opened new Natus Medical Inc positions in Q4 2013 and 10 closed out, a net change of +30 holders.
  • The largest Natus Medical Inc buyer in Q4 2013 was Eagle Asset Management, an estimated $7.33M added.
  • The largest Natus Medical Inc seller in Q4 2013 was Broadfin Capital, an estimated $29.1M sold.

Based on aggregated 13F filings for Q4 2013.